CAV1 and pulmonary hypertension: In another rat model of severe pulmonary hypertension, induced by a single subcutaneous injection of the VEGFR inhibitor SU5416 and subsequent 3-week exposure to chronic hypoxia, Cav1 expression was selectively reduced in the arterial lesions [82].